← Back to Search

FallsTalk-C for Falls (FT-C Trial)

N/A
Waitlist Available
Led By Victoria Panzer, PhD
Research Sponsored by Brookside Research & Development Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly for up to one year
Awards & highlights

FT-C Trial Summary

This study is evaluating whether a new intervention may help reduce the number of falls for individuals with memory loss or dementia.

FT-C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly for up to one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly for up to one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change of Residence
Rate of falls
Secondary outcome measures
Activity-Specific Balance Confidence scale
Burden Scale for Family Caregivers
Caregiver Falls Prevention Concerns
+1 more

FT-C Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: FallsTalk-CExperimental Treatment2 Interventions
FallsTalk CG intervention
Group II: FallsTalkActive Control1 Intervention
FallsTalk intervention
Group III: PostCardOnlyActive Control1 Intervention
Postcard only- Control group

Find a Location

Who is running the clinical trial?

Brookside Research & Development CompanyLead Sponsor
National Institute on Aging (NIA)NIH
1,662 Previous Clinical Trials
28,004,514 Total Patients Enrolled
Alzheimer's AssociationOTHER
89 Previous Clinical Trials
40,663 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Apr 2025